Mirion Technologies (NYSE:MIR) Sets New 12-Month Low Following Analyst Downgrade

Mirion Technologies, Inc. (NYSE:MIR)’s share price reached a new 52-week low on Thursday after Citigroup lowered their price target on the stock from $28.00 to $24.00. Citigroup currently has a buy rating on the stock. Mirion Technologies traded as low as $14.11 and last traded at $14.5850, with a volume of 10606027 shares. The stock had previously closed at $16.79.

MIR has been the subject of a number of other research reports. Morgan Stanley reduced their price target on Mirion Technologies from $27.00 to $25.00 and set an “equal weight” rating for the company in a report on Monday, July 13th. Weiss Ratings lowered Mirion Technologies from a “sell (d+)” rating to a “sell (d)” rating in a research note on Monday, July 20th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $23.00 price objective on shares of Mirion Technologies in a research report on Wednesday. Finally, B. Riley Financial reduced their target price on Mirion Technologies from $29.00 to $27.00 and set a “buy” rating for the company in a research note on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $26.25.

Insider Activity at Mirion Technologies

In related news, CAO Christopher A. Moore sold 8,400 shares of Mirion Technologies stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $19.64, for a total transaction of $164,976.00. Following the completion of the sale, the chief accounting officer owned 22,157 shares of the company’s stock, valued at approximately $435,163.48. The trade was a 27.49% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 6.30% of the company’s stock.

Trending Headlines about Mirion Technologies

Here are the key news stories impacting Mirion Technologies this week:

• Positive Sentiment: Mirion maintained its 2026 outlook and expects second-half organic revenue growth of approximately 7.5% to 11.2%, alongside adjusted EBITDA margins of 27% to 29%. This indicates management still expects solid underlying growth and profitability improvement. Mirion maintains 2026 outlook
• Positive Sentiment: Citigroup lowered its price target to $24 from $28 but retained a “buy” rating, implying substantial upside from the current trading level. B. Riley likewise maintained a “buy” rating while reducing its target to $27 from $29. Citigroup price target update
• Neutral Sentiment: Mirion’s latest quarterly results showed adjusted earnings of $0.12 per share, ahead of the $0.10 consensus estimate, while revenue rose 19.7% year over year to $266.8 million but fell slightly short of expectations. The mixed results highlight strong growth but limited near-term execution upside. Mirion Q2 2026 earnings call summary
• Negative Sentiment: Northland Securities reduced its Q3 2026 EPS estimate to $0.12 from $0.14 and lowered its FY2027 forecast to $0.71 from $0.72. Although the cuts are modest, they signal softer expectations for near-term earnings growth and may contribute to selling pressure.

Hedge Funds Weigh In On Mirion Technologies

A number of hedge funds have recently added to or reduced their stakes in the stock. Royal Bank of Canada increased its position in shares of Mirion Technologies by 258.2% in the first quarter. Royal Bank of Canada now owns 98,828 shares of the company’s stock worth $1,433,000 after purchasing an additional 71,241 shares during the period. AQR Capital Management LLC lifted its position in Mirion Technologies by 124.3% during the first quarter. AQR Capital Management LLC now owns 199,211 shares of the company’s stock worth $2,889,000 after purchasing an additional 110,399 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Mirion Technologies by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 122,962 shares of the company’s stock worth $1,783,000 after purchasing an additional 5,366 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Mirion Technologies by 8.8% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 434,583 shares of the company’s stock worth $6,301,000 after buying an additional 34,973 shares in the last quarter. Finally, Cetera Investment Advisers acquired a new stake in Mirion Technologies during the second quarter worth about $288,000. Institutional investors own 78.51% of the company’s stock.

Mirion Technologies Trading Up 1.0%

The firm’s fifty day simple moving average is $17.09 and its 200 day simple moving average is $19.72. The stock has a market capitalization of $3.75 billion, a P/E ratio of 149.89 and a beta of 1.03. The company has a debt-to-equity ratio of 0.64, a quick ratio of 2.63 and a current ratio of 3.20.

Mirion Technologies (NYSE:MIR) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $0.12 earnings per share for the quarter, topping analysts’ consensus estimates of $0.10 by $0.02. The company had revenue of $266.80 million during the quarter, compared to the consensus estimate of $269.32 million. Mirion Technologies had a net margin of 2.39% and a return on equity of 6.59%. The firm’s quarterly revenue was up 19.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.11 EPS. Mirion Technologies has set its FY 2026 guidance at 0.480-0.550 EPS. As a group, equities research analysts forecast that Mirion Technologies, Inc. will post 0.54 EPS for the current fiscal year.

Mirion Technologies Company Profile

Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.

Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.